Innovating Protein Technologies
for Therapeutics and Vaccine Design
Developing a new vaccine is the biggest
contribution one can make to global health.
We are developing new vaccine
technologies to overcome major health
challenges, including pandemic viruses,
malaria and influenza.
Our protein assemblies are being advanced
to activate the immune system to kill
cancer, identify the spread of cancer cells,
and image tumours for early diagnosis.
We have established a range of
technologies to transform how proteins can
be connected, for therapeutics, new
materials and diagnostics.
EXPLORING AND ADVANCING HUMAN LIFE
The Department of Pharmacology at Cambridge studies life from
the levels of atoms to organisms. We are also part of a
collaborative network of researchers
from basic physical sciences (physics, chemistry, engineering)
and from translational medicine up to clinical trials.
MEET THE EXPERTS
We are a mix of graduate students, postdoctoral and
undergraduate researchers with diverse backgrounds and
nationalities, seeking to create new directions in synthetic biology.
HOWARTH LAB HOMEPAGE
Inspired by extraordinary molecular features from the natural world,
our research develops new approaches for disease prevention, diagnosis and therapy,
as well as for fundamental insight into how biological systems function.
READ ALL ABOUT IT
Catch up on our latest Papers, Events and Entrepreneurship.
From Sept 2022, the Lab has relocated to Cambridge University Department of Pharmacology.
Any sufficiently advanced technology
is indistinguishable from magic.
- Arthur C. Clarke
Department of Pharmacology,
University of Cambridge,
Tennis Court Road,
t: 01223 334176
2023 Mark Howarth. All rights reserved.